– Bloomberg
Oppenheimer Downgrades Amyris to Perform
Oppenheimer analyst Colin Rusch downgrades Amyris (NASDAQ:AMRS) from Outperform to Perform.
Related Posts
What’s Up With Aterian Shares Today?
Aterian Inc (NASDAQ: ATER) is trading higher Monday on abnormally high volume as retail traders discuss the stock's short squeeze potential across social media platforms.
While Apple Struggles To Replace Legendary Designer Jony Ive, He’s Busy Doing Something Special For UK’s King Charles
Apple Inc. (NASDAQ:AAPL) might be struggling to find someone suitable to fill the shoes of Jony Ive after…
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday.